E-Cigarette Tipping Points Revisited, with Historical Perspective: A Mini Review

In August of 2017, I wrote about the topic of e-cigarette tipping points for the first time. 1st In this article, I return to this topic [2] to see what, if anything, has changed since then. E-cigarettes claimed to have reached two big tipping points when the 2017 paper was published. The first was because of their widespread use, with an estimated 10% of the adult population in the United States using or having used e-cigarette products [3]. The second had to do with public perceptions of protection and benefit to public health [4]. I noted at the time that the American Food and Drug Administration (FDA) was projecting a harshly negative view of e-cigarette safety, only grudgingly recognizing that there could be personal and public health benefits. Since then, the FDA and the broader American tobacco control culture have become so hostile to e-cigarettes that each product is now facing forced withdrawal from the market unless the manufacturer can apply a “viable” Pre-Market Tobacco Application as soon as possible (PMTA). Because of the expense of the studies needed to prepare the application, as previously mentioned [1], such an application is physically impossible for 99 percent or more of e-cigarette manufacturers. This essay will discuss how and why the majority of the e-cigarette industry in the United States is on its way out, and what, if anything, can be done about it.

Author (s) Details

Joel L. Nitzkin
R Street Institute, Washington DC, c/o JLN, MD Associates, LLC, New Orleans, Louisiana, USA.

View Book :- https://stm.bookpi.org/CDHR-V7/article/view/925

Leave a Reply

Your email address will not be published. Required fields are marked *